Concepedia

Holly Legault

HL

Statistics

Publications

15

Citations

1.2K

H-Index

13

Active since

2008

Affiliations

Moderna Therapeutics (United States)(Current)

Benchmark Research (United States)

Dermatology Research Center

Inflammation Research Foundation

Roche (United States)

Holly Legault is an author at Moderna Therapeutics (United States) specializing in immunology, vaccination, and infectious diseases.

Publications per year

2008–2022

15

Publications

15

Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis

Angela Choi, Matthew Koch, Laurence Chu et al. · Nature Medicine · 2021 · 449 citations · Full text

, , +17

Pathways Activated during Human Asthma Exacerbation as Revealed by Gene Expression Patterns in Blood

Unnur Steina Björnsdóttir, Stephen T. Holgate, Padmalatha S. Reddy et al. · PLoS ONE · 2011 · 124 citations · Full text

, , +17

Serum Neutralizing Activity of mRNA-1273 against SARS-CoV-2 Variants

Angela Choi, Matthew Koch, Groves Dixon et al. · Journal of Virology · 2021 · 116 citations · Full text

, , +12

Immune response to SARS-CoV-2 after a booster of mRNA-1273: an open-label phase 2 trial

Laurence Chu, Keith Vrbicky, David C. Montefiori et al. · Nature Medicine · 2022 · 104 citations · Full text

, , +17

Preliminary Analysis of Safety and Immunogenicity of a SARS-CoV-2 Variant Vaccine Booster

Angela Choi, Matthew Koch, LingZhi Ma et al. · medRxiv · 2021 · 90 citations · Full text

, , +17

1–5 of 15